DK0787796T3 - Beskyttende epitoper fra adenylat-cyclase-hæmolysin (AC-Hly) og deres anvendelse til behandling eller forebyggelse af Bordetella-infektioner - Google Patents

Beskyttende epitoper fra adenylat-cyclase-hæmolysin (AC-Hly) og deres anvendelse til behandling eller forebyggelse af Bordetella-infektioner

Info

Publication number
DK0787796T3
DK0787796T3 DK96401402T DK96401402T DK0787796T3 DK 0787796 T3 DK0787796 T3 DK 0787796T3 DK 96401402 T DK96401402 T DK 96401402T DK 96401402 T DK96401402 T DK 96401402T DK 0787796 T3 DK0787796 T3 DK 0787796T3
Authority
DK
Denmark
Prior art keywords
hly
prevention
treatment
adenylate cyclase
protective epitopes
Prior art date
Application number
DK96401402T
Other languages
English (en)
Inventor
Nicole Guiso
Fotini Betsou
Peter Sebo
Farida Nato
Stephanie Landais
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Application granted granted Critical
Publication of DK0787796T3 publication Critical patent/DK0787796T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82Proteins from microorganisms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82Proteins from microorganisms
    • Y10S530/825Bacteria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK96401402T 1995-06-30 1996-06-25 Beskyttende epitoper fra adenylat-cyclase-hæmolysin (AC-Hly) og deres anvendelse til behandling eller forebyggelse af Bordetella-infektioner DK0787796T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9507945A FR2736064B1 (fr) 1995-06-30 1995-06-30 Epitopes protecteurs de l'adenyl cyclase-hemolysine(ac-hty). leur application au traitement ou a la prevention des infections par bordetella

Publications (1)

Publication Number Publication Date
DK0787796T3 true DK0787796T3 (da) 2009-04-20

Family

ID=9480602

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96401402T DK0787796T3 (da) 1995-06-30 1996-06-25 Beskyttende epitoper fra adenylat-cyclase-hæmolysin (AC-Hly) og deres anvendelse til behandling eller forebyggelse af Bordetella-infektioner

Country Status (11)

Country Link
US (3) US6309648B1 (da)
EP (1) EP0787796B9 (da)
JP (1) JP4302784B2 (da)
AT (1) ATE420951T1 (da)
AU (1) AU5625796A (da)
CA (1) CA2180280A1 (da)
DE (1) DE69637812D1 (da)
DK (1) DK0787796T3 (da)
ES (1) ES2320392T3 (da)
FR (1) FR2736064B1 (da)
PT (1) PT787796E (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2646776B1 (fr) * 1989-05-12 1994-06-03 Pasteur Institut Utilisation de preparations vaccinantes a base d'adenyl cyclase ou de bacteries les produisant en tant qu'antigenes protecteurs contre les effets des bordetella
FR2728170A1 (fr) * 1994-12-15 1996-06-21 Pasteur Institut Vaccin de type acellulaire anti-bordetella
US7462472B2 (en) * 2001-11-02 2008-12-09 The University Of Chicago Methods and compositions relating to anthrax pathogenesis
EP1489092A1 (en) * 2003-06-18 2004-12-22 Institut Pasteur Modified Bordetella adenylate cyclase comprising or lacking CD11b/CD18 interaction domain and uses thereof
WO2008088771A2 (en) * 2007-01-12 2008-07-24 Cornell Research Foundation, Inc. Adenylyl cyclases as novel targets for the treatment of infection by eukaryotic pathogens
CN101636157A (zh) * 2007-01-12 2010-01-27 康乃尔研究基金会有限公司 作为抗菌干预的新型靶的腺苷酰环化酶
US20100112009A1 (en) * 2008-11-03 2010-05-06 Institut Pasteur Acellular antibordetella vaccine
US20190071706A1 (en) 2016-04-04 2019-03-07 University Of Virginia Patent Foundation Compositions and methods for preventing and treating disease

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8412207D0 (en) * 1984-05-12 1984-06-20 Wellcome Found Antigenic preparations
FR2590483B1 (fr) 1985-11-22 1988-12-09 Pasteur Institut Antigenes purifies ayant des proprietes vaccinantes contre b. pertussis, moyens notamment adns recombinants pour les produire et compositions de vaccins les contenant
FR2606789B1 (fr) 1986-11-17 1991-05-31 Pasteur Institut Preparations d'adenylate cyclase purifiees, procede d'obtention de ces preparations et leurs applications biologiques
DE3781541T2 (de) 1986-12-23 1993-05-06 Univ Leland Stanford Junior Modifiziertes pertussistoxin.
EP0338170A1 (en) 1988-04-19 1989-10-25 Institut Pasteur Immunoprotective antigenic protein against pathogenic bacteria
EP0338169B1 (en) 1988-04-19 1996-07-24 Institut Pasteur Method for obtaining protective antigens against bordetella infections and toxic processes
FR2638169B1 (fr) * 1988-10-25 1991-01-11 Pasteur Institut Derives d'adenyl cyclase et leurs utilisations biologiques
FR2646776B1 (fr) 1989-05-12 1994-06-03 Pasteur Institut Utilisation de preparations vaccinantes a base d'adenyl cyclase ou de bacteries les produisant en tant qu'antigenes protecteurs contre les effets des bordetella
FR2728170A1 (fr) * 1994-12-15 1996-06-21 Pasteur Institut Vaccin de type acellulaire anti-bordetella

Also Published As

Publication number Publication date
JP4302784B2 (ja) 2009-07-29
FR2736064B1 (fr) 1997-09-05
PT787796E (pt) 2009-04-03
DE69637812D1 (de) 2009-03-05
JPH09187284A (ja) 1997-07-22
EP0787796B9 (fr) 2009-08-05
EP0787796A1 (fr) 1997-08-06
EP0787796B1 (fr) 2009-01-14
CA2180280A1 (fr) 1996-12-31
AU5625796A (en) 1997-01-23
US20060292161A1 (en) 2006-12-28
ATE420951T1 (de) 2009-01-15
US6994854B1 (en) 2006-02-07
FR2736064A1 (fr) 1997-01-03
ES2320392T3 (es) 2009-05-21
US7902349B2 (en) 2011-03-08
US6309648B1 (en) 2001-10-30

Similar Documents

Publication Publication Date Title
Turnbull Anthrax vaccines: past, present and future
Thomas et al. Human serum antibody responses to Bordetella pertussis infection and pertussis vaccination
MX9203458A (es) Segmentos inmunogenicos que contienen glicoproteinas quimericas de las glicoproteinas de virus sincitial respiratorio humano.
DE69331901D1 (de) Impfstoff auf urease-basis gegen helicobacter infektionen
DK0612250T3 (da) Fremgangsmåder og præparater med relation til nyttige Moraxella catarrhalis-antigener
CA2231603A1 (en) Chicken interleukin-15 and uses thereof
ATE127345T1 (de) Stressproteine und verwendungen dafür.
ATE181572T1 (de) Ospa proteine von borrelia burgdorferi untergruppen, dafür kodierende gene sowie impfstoffe
NYIKA et al. A DNA vaccine protects mice against the rickettsial agent Cowdria ruminantium
FI892131A0 (fi) Analoger till underenheter av bordetellatoxin, vilka haerstammar fraon hybrid-dna.
DE69731659D1 (de) Impfstoffzubereitung bestehend aus untereinheiten des respiratorischen synzytialvirus (rsv)
DE69637812D1 (de) Schützende Epitope von Adenylate-Zyklase-Hämolysin(AC-Hly) und ihre Verwendung zur Behandlung oder Verhütung von Bordetella-Infektionen
EP0556333A4 (de) Avirulente mikroben und ihre verwendung: salmonella typhi.
Finger et al. Bordetella
ATE62270T1 (de) Herstellung des e.coli-lt-benterotoxinunterteils.
ATE140729T1 (de) Verfahren zur gewinnung von schutzantigenen gegen bordetella-infektionen und toxische prozesse
BR9815496A (pt) Vacinas de ácido nucléico que codificam proteìna gde vìrus sincicial respiratório
NO932009L (no) Subenhet vaksine for neisseria meningitidis infeksjoner og tilsvarende rensede subenheter
DK601687A (da) Rensede adenyl-cyclase-praeparater, fremgangsmaade til opnaaelse af saadanne praeparater og deres biologiske anvendelser
DE69015314D1 (de) Verwendung von adenylzyclase als vakzin gegen bordetella.
DK1005487T3 (da) Ydre 74 kD-membranprotein fra Moraxella catarrhalis
Gross et al. Differential regulation of Bordetella pertussis virulence factors
DK0542895T3 (da) Krydsreaktiv influenza A immunisering
Cox The cloning and characterization of three genes in Bordetella avium
Fernald Immunological control of Mycoplasma infection: A review.